Latest News and Press Releases

Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "CD5 Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025" report has been added to ...

Dublin, July 09, 2025 (GLOBE NEWSWIRE) -- The "Peptide Drug Conjugate Market, Drug Sales, Price, Dosage & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's...

WESTON, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for...

Dublin, June 13, 2025 (GLOBE NEWSWIRE) -- The "Global Multispecific Antibodies Market, Drug Sales, Dosage, Price & Clinical Trials Insight 2030" report has been added to ...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) Cell Therapy Clinical Trials, Proprietary Technologies, Collaborations & Market Opportunity Insight 2025" has been added to ...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" has been added to ResearchAndMarkets.com's...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "VISTA Inhibitor Clinical Trials, Drug Development Opportunities & Patent Insight 2025" report has been added to ResearchAndMarkets.com's offering. ...

Applied Pharmaceutical Innovation (API) appoints Dr. Launa Aspeslet as Chief Translational Officer to drive life sciences commercialization in Canada.

Salt Lake City, UT, April 22, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, will present preliminary data...

HUNTSVILLE, Ala., April 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug...